Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

NCT02601157 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02601157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 18, 2016
Completion date
August 14, 2022
Enrollment
2,173 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

non-st segment elevation myocardial infarction, stable angina, unstable angina